Cargando…

Advanced Merkel cell carcinoma of the lower extremity treated with surgery and isolated pelvic and limb perfusion using Melphalan: A case of unexpected long-term survival

INTRODUCTION: Merkel cell carcinoma (MCC) is a rare, neuroendocrine skin tumor, with high frequency of locoregional recurrence, metastases, and poor prognosis. Locoregional MCC recurrence in the extremities can pose considerable treatment challenges. We report a case of long-term survival in a femal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guadagni, S., Chiominto, A., Mackay, A.R., Farina, A.R., Cappabianca, L., Puccica, I., Valiyeva, S., Clementi, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626978/ https://www.ncbi.nlm.nih.gov/pubmed/31302319 http://dx.doi.org/10.1016/j.ijscr.2019.06.064

Ejemplares similares

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study
por: Guadagni, Stefano, et al.
Publicado: (2017)

A pilot study of alternative TrkAIII splicing in Merkel cell carcinoma: a potential oncogenic mechanism and novel therapeutic target
por: Cappabianca, Lucia, et al.
Publicado: (2019)

Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A
por: Guadagni, Stefano, et al.
Publicado: (2020)

Surgical versus percutaneous isolated pelvic perfusion (IPP) for advanced melanoma: comparison in terms of melphalan pharmacokinetic pelvic bio-availability
por: Guadagni, Stefano, et al.
Publicado: (2017)

Isolated Limb Perfusion with Melphalan and TNF-α in the Treatment of Extremity Sarcoma
por: Verhoef, Cornelis, et al.
Publicado: (2007)

The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
por: Scott, R. N., et al.
Publicado: (1992)

Successful laparoscopic trans-peritoneal repair of an incisional inguinal hernia, resulting from deep lymph node dissection for melanoma: A case report
por: Clementi, M., et al.
Publicado: (2020)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
por: Johansson, Junko, et al.
Publicado: (2018)

Advantage of laparoscopic resection for pelvic Schwannoma: Case report and review of the literature
por: Di Furia, Marino, et al.
Publicado: (2018)

Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats
por: Wilt, J H W de, et al.
Publicado: (1999)

Surgical site infections in patients undergoing breast oncological surgery during the lockdown: An unexpected lesson from the COVID-19 pandemic
por: Cappelli, Sonia, et al.
Publicado: (2022)

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.
por: Klaase, J. M., et al.
Publicado: (1994)

The Alternative TrkAIII Splice Variant, a Targetable Oncogenic Participant in Human Cutaneous Malignant Melanoma
por: Cappabianca, Lucia, et al.
Publicado: (2023)

Mitomycin C hypoxic pelvic perfusion for unresectable recurrent rectal cancer: pharmacokinetic comparison of surgical and percutaneous techniques
por: Guadagni, Stefano, et al.
Publicado: (2017)

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
por: Guadagni, Stefano, et al.
Publicado: (2017)

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion
por: de Wilt, J H W, et al.
Publicado: (2000)

Isolated hepatic perfusion in the pig with TNF-alpha with and without melphalan.
por: Borel Rinkes, I. H., et al.
Publicado: (1997)

TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature
por: Podleska, L E, et al.
Publicado: (2015)

TNF-alpha and melphalan-based isolated limb perfusion: no evidence supporting the early destruction of tumour vasculature
por: Podleska, L E, et al.
Publicado: (2015)

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.
por: Nooijen, P. T., et al.
Publicado: (1996)

Circulating tumour cell liquid biopsy in selecting therapy for recurrent cutaneous melanoma with locoregional pelvic metastases: a pilot study
por: Guadagni, Stefano, et al.
Publicado: (2020)

Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
por: Ruschulte, Heiner, et al.
Publicado: (2013)

Laparoscopic treatment of obstructed internal supravesical hernia: A cases series and rewiev of the literature
por: Marco, Clementi, et al.
Publicado: (2018)

Unexpected maspin immunoreactivity in Merkel cell carcinoma
por: Turdean, Sabin Gligore, et al.
Publicado: (2015)

Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies
por: Thompson, J F, et al.
Publicado: (2001)

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions
por: de Wilt, J H W, et al.
Publicado: (2000)

An unexpected ECG finding
por: Kuiper, M.J., et al.
Publicado: (2015)

Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
por: Johansson, Junko, et al.
Publicado: (2019)

Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study
por: Guadagni, Stefano, et al.
Publicado: (2019)

Chemosaturation with percutaneous hepatic perfusion of melphalan for metastatic uveal melanoma
por: Modi, Sachin, et al.
Publicado: (2022)

Intraluminal ileal tumour after right hemicolectomy for cancer: An implantation recurrence or a new cancer? A case report
por: Clementi, Marco, et al.
Publicado: (2017)

Isolated Hepatic Perfusion with 200 mg Melphalan for Advanced Noncolorectal Liver Metastases
por: van Iersel, Liselot B. J., et al.
Publicado: (2008)

Merkel-cell carcinoma of the upper limb
por: M. Rojoa, Djamila, et al.
Publicado: (2018)

Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
por: Farina, Antonietta Rosella, et al.
Publicado: (2020)

Isolated Limb Perfusion with Tumor Necrosis Factor Alpha and Melphalan for Locally Advanced Soft Tissue Sarcoma: Three Time Periods at Risk for Amputation
por: van Ginkel, Robert J., et al.
Publicado: (2007)

Percutaneous Hepatic Perfusion (PHP) with Melphalan in Liver-Dominant Metastatic Uveal Melanoma: The German Experience
por: Dewald, Cornelia L. A., et al.
Publicado: (2021)

The effects of perfusion conditions on melphalan distribution in the isolated perfused rat hindlimb bearing a human melanoma xenograft.
por: Wu, Z. Y., et al.
Publicado: (1997)

Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy
por: Huis in ’t Veld, Eva A., et al.
Publicado: (2018)

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.
por: Kuppen, P. J., et al.
Publicado: (1997)

Factors influencing the chemosensitization of melphalan by misonidazole.
por: Randhawa, V. S., et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_h4eb1hthnl7s1freuoijv40uf9